MktsMarkets

Quest Diagnostics Incorporated
NYSE: DGXKey statistics
DGX News
Stories mentioning DGX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 2,895,000 | 2,806,000 | 2,816,000 | 2,761,000 | 2,652,000 | 2,621,000 | 2,488,000 | 2,397,000 |
| Cost of Goods Sold | 1,953,000 | 1,896,000 | 1,867,000 | 1,818,000 | 1,789,000 | 1,763,000 | 1,677,000 | 1,593,000 |
| Gross Profit | 942,000 | 910,000 | 949,000 | 943,000 | 863,000 | 858,000 | 811,000 | 804,000 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 504,000 | 504,000 | 501,000 | 486,000 | 476,000 | 466,000 | 448,000 | 416,000 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 399,000 | 386,000 | 386,000 | 438,000 | 346,000 | 361,000 | 330,000 | 355,000 |
| Interest Income | ||||||||
| Interest Expense | 47,000 | |||||||
| Other Expense | (2,000) | 8,000 | 8,000 | 13,000 | (3,000) | 3,000 | 15,000 | 3,000 |
| Pretax Income | ||||||||
| Tax Provision | 74,000 | 81,000 | 77,000 | 97,000 | 59,000 | 68,000 | 65,000 | 74,000 |
| Net Income (Loss) | 252,000 | 245,000 | 245,000 | 282,000 | 220,000 | 222,000 | 226,000 | 229,000 |
| Earnings Per Share (Basic) | 2.27 | 2.21 | 2.18 | 2.51 | 1.97 | 2.00 | 2.01 | 2.05 |
| Earnings Per Share (Diluted) | 2.24 | 2.17 | 2.16 | 2.47 | 1.94 | 1.96 | 1.99 | 2.03 |
| Weighted Average Shares Outstanding (Basic) | 110,000 | 111,000 | 112,000 | 112,000 | 111,000 | 111,000 | 112,000 | 111,000 |
| Weighted Average Shares Outstanding (Diluted) | 112,000 | 113,000 | 113,000 | 113,000 | 113,000 | 113,000 | 113,000 | 112,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About DGX
Quest Diagnostics Incorporated (NYSE: DGX) is a stock listed on the New York Stock Exchange under the ticker symbol DGX. It last traded at $259.69 (Nov 18, 2026, 4:00 PM ET), up 1.3% on the day. That gives Quest Diagnostics a market capitalisation of $28.2B and a price-to-earnings ratio of 25.0.
Over the past 52 weeks DGX has traded between $171.18 and $263.19.
Revenue for the quarter ended Mar 31, 2026 was $2.9B; net income $252.0M. Revenue was up 9.2% from $2.7B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $2.9B | $252.0M | 8.7% |
| Dec 31, 2025 | $2.8B | $245.0M | 8.7% |
| Sep 30, 2025 | $2.8B | $245.0M | 8.7% |
| Jun 30, 2025 | $2.8B | $282.0M | 10.2% |
From Quest Diagnostics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…